However, DBP mixtures are complex, and we felt it worthwhile to evaluate the possibility of an interaction between DBPs and slow/rapid acetylation genotypes of NAT2 in risk of bladder cancer. The gene discussed is NAT2; the disease is urinary bladder carcinoma.